Lite Strategy, Inc. (LITS) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Lite Strategy, Inc. (LITS) closed at USD 1.17 on 2026-10-14, a change of -39.4 % over the past year, with a market capitalization of USD 36.34M.

Lite Strategy, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Lite Strategy, Inc. key figures

Previous close

USD 1.17 (2026-10-14)

1-year change

-39.4 %

Market cap

USD 36.34M

Enterprise value

USD 30.63M

P/E ratio (trailing)

-0.59

P/E ratio (forward)

n/a

EPS (trailing)

-2.03

EPS (forward)

n/a

PEG ratio

2.22

Price to book

0.93

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.21

Employees

5

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Lite Strategy, Inc.

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Lite Strategy, Inc. and compare it with other stocks.